“We must question why Bavarian Nordic refuses to adjust its unconscionable approach to pricing and access,” wrote the director of Public Citizen’s Access to Medicines program.
You must log in or register to comment.
a pharmaceutical company profiteering off a health crisis? nah …
Obviously.